Tumor suppressor role of protein 4.1B/DAL-1

Zi Wang1, Ji Zhang, Mao Ye

  • 1Molecular Biology Research Center, School of Life Sciences, Central South University, 110 Xiangya Road, Changsha, 410078, China.

Insights

Protein 4.1B/DAL-1, a tumor suppressor, links cell membranes to the cytoskeleton and regulates cell growth. Its loss is linked to tumor progression, highlighting its anti-tumor potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Protein 4.1B/DAL-1 is a membrane skeletal protein crucial for cell-cell contact.
  • It acts as an adapter, connecting the plasma membrane to the cytoskeleton and signaling pathways.
  • It regulates cell motility, adhesion, growth, and differentiation.

Purpose of the Study:

  • To review the structure and function of Protein 4.1B/DAL-1.
  • To explore its role in cell-cell adhesion and cytoskeleton organization.
  • To investigate its tumor suppressor activity and implications in cancer pathogenesis.

Main Methods:

  • Literature review focusing on Protein 4.1B/DAL-1 structure and interactions.
  • Analysis of studies on Protein 4.1B/DAL-1 expression in normal and tumor tissues.
  • Examination of research on the functional consequences of Protein 4.1B/DAL-1 inactivation.

Main Results:

  • Protein 4.1B/DAL-1 is essential for establishing epithelial-like structures.
  • Loss or down-regulation of Protein 4.1B/DAL-1 expression is common in various tumors.
  • This down-regulation correlates with tumor progression and suggests a tumor suppressor role.

Conclusions:

  • Protein 4.1B/DAL-1 is a key regulator of cell structure and adhesion.
  • Its inactivation contributes to tumor development, making it a target for cancer therapy.
  • Further research into Protein 4.1B/DAL-1's anti-tumor activities is warranted.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

1.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K